Browse by Uncontrolled Keywords

Export as [feed] Atom [feed] RSS
Group by: Year | Authors/Creators | Item Type | Full Text
Jump to: 2011 | 2010 | 2007 | 2006 | 2005 | 2003 | 2002 | 2001 | 1999
Number of items: 20.

2011

Gilbert, CE; Zin, A; Darlow, B; (2011) Bevacizumab for Retinopathy of Prematurity. The New England journal of medicine, 364 (24). 2359-60; author reply 2361-2. ISSN 0028-4793 DOI: https://doi.org/10.1056/NEJMc1103460#SA2
[img]

Reich, K; Burden, AD; Eaton, JN; Hawkins, NS; (2011) Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials. The British journal of dermatology, 166. pp. 179-88. ISSN 0007-0963 DOI: https://doi.org/10.1111/j.1365-2133.2011.10583.x Full text not available from this repository.

2010

Kirtane, AJ; Parise, H; Mehran, R; Moses, JW; Fahy, M; Bertrand, ME; Ohman, EM; White, HD; Feit, F; Colombo, A; +6 more... McLaurin, BT; Cox, DA; Ware, JH; Pocock, SJ; Lansky, AJ; Stone, GW; (2010) Comparison of Catheterization Laboratory Initiated Abciximab and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes (an ACUITY Substudy). The American journal of cardiology, 106 (2). pp. 180-186. ISSN 0002-9149 DOI: https://doi.org/10.1016/j.amjcard.2010.03.015 Full text not available from this repository.

Punekar, YS; Sunderland, T; Hawkins, N; Lindsay, J; (2010) Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's disease. Value in health, 13. pp. 188-195. ISSN 1098-3015 DOI: https://doi.org/10.1111/j.1524-4733.2009.00658.x Full text not available from this repository.

2007

Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: https://doi.org/10.1093/rheumatology/kem221 Full text not available from this repository.

Raqib, R; Alam, DS; Sarker, P; Ahmad, SM; Ara, G; Yunus, M; Moore, SE; Fuchs, G; (2007) Low birth weight is associated with altered immune function in rural Bangladeshi children: a birth cohort study. The American journal of clinical nutrition, 85 (3). pp. 845-52. ISSN 0002-9165 http://researchonline.lshtm.ac.uk/id/eprint/10041 Full text not available from this repository.

2006

Barrett, A; Roques, T; Small, M; Smith, RD; (2006) How much will Herceptin really cost? BMJ, 333 (7578). pp. 1118-20. ISSN 1468-5833 DOI: https://doi.org/10.1136/bmj.39008.624051.BE
[img]

Woolacott, N; Bravo Vergel, Y; Hawkins, N; Kainth, A; Khadjesari, Z; Misso, K; Light, K; Asseburg, C; Palmer, S; Claxton, K; +3 more... Bruce, I; Sculpher, M; Riemsma, R; (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 10. iii-iv, xiii-xvi, 1-239. ISSN 1366-5278 http://researchonline.lshtm.ac.uk/id/eprint/2534859
[img]

Woolacott, N; Hawkins, N; Mason, A; Al., E; (2006) Etanercept and efalizumab for the treatment of psoriasis: a systematic review. Health technology assessment (Winchester, England), 10. 1-233, i-iv. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta10460
[img]

2005

Godicke, J; Flather, M; Noc, M; Gyongyosi, M; Arntz, HR; Grip, L; Gabriel, HM; Huber, K; Nugara, F; Schroer, J; +4 more... Svensson, L; Wang, DL; Zorman, S; Montalescot, G; (2005) Early versus periprocedural administration of abciximab for primary angioplasty: A pooled analysis of 6 studies. American heart journal, 150 (5). ISSN 0002-8703 DOI: https://doi.org/10.1016/j.ahj.2005.07.026 Full text not available from this repository.

2003

Donelli, G; Fiorentini, C; Matarrese, P; Falzano, L; Cardines, R; Mastrantonio, P; Payne, DW; Titball, RW; (2003) Evidence for cytoskeletal changes secondary to plasma membrane functional alterations in the in vitro cell response to Clostridium perfringens epsilon-toxin. Comparative immunology, microbiology and infectious diseases, 26 (3). pp. 145-156. ISSN 0147-9571 DOI: https://doi.org/10.1016/S0147-9571(02)00052-8 Full text not available from this repository.

Moore, TA; Lau, HY; Cogen, AL; Monteleon, CL; Standiford, TJ; (2003) Anti-tumor necrosis factor-alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. Shock (Augusta, Ga), 20 (4). pp. 309-15. ISSN 1073-2322 DOI: https://doi.org/10.1097/01.shk.0000087203.34916.45 Full text not available from this repository.

2002

Atkins, T; Prior, R; Mack, K; Russell, P; Nelson, M; Prior, J; Ellis, J; Oyston, PCF; Dougan, G; Titball, RW; (2002) Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. Journal of medical microbiology, 51 (7). pp. 539-47. ISSN 0022-2615 http://researchonline.lshtm.ac.uk/id/eprint/17731 Full text not available from this repository.

2001

Prior, JL; Hitchen, PG; Williamson, ED; Reason, AJ; Morris, HR; Dell, A; Wren, BW; Titball, RW; (2001) Characterization of the lipopolysaccharide of Yersinia pestis. Microbial pathogenesis, 30 (2). pp. 49-57. ISSN 0882-4010 DOI: https://doi.org/10.1006/mpat.2000.0411 Full text not available from this repository.

Tan, BH; Nason, E; Staeuber, N; Jiang, WR; Monastryrskaya, K; Roy, P; (2001) RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells. Journal of virology, 75 (8). pp. 3937-3947. ISSN 0022-538X DOI: https://doi.org/10.1128/JVI.75.8.3937-3947.2001 Full text not available from this repository.

Watano, K; Iwabuchi, K; Fujii, S; Ishimori, N; Mitsuhashi, S; Ato, M; Kitabatake, A; Onoe, K; (2001) Allograft inflammatory factor-1 augments production of interleukin-6, - 10 and -12 by a mouse macrophage line. Immunology, 104 (3). pp. 307-16. ISSN 0019-2805 DOI: https://doi.org/10.1046/j.1365-2567.2001.01301.x Full text not available from this repository.

Wolf, K; Fischer, E; Mead, D; Zhong, G; Peeling, R; Whitmire, B; Caldwell, HD; (2001) Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infection and immunity, 69 (5). pp. 3082-91. ISSN 0019-9567 DOI: https://doi.org/10.1128/IAI.69.5.3082-3091.2001 Full text not available from this repository.

1999

Benjamin, PA; Ling, IT; Clottey, G; Spencer Valero, LM; Ogun, SA; Fleck, SL; Walliker, D; Morgan, WD; Birdsall, B; Feeney, J; +1 more... Holder, AA; (1999) Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies. Molecular and biochemical parasitology, 104 (2). pp. 147-156. ISSN 0166-6851 DOI: https://doi.org/10.1016/S0166-6851(99)00142-5 Full text not available from this repository.

This list was generated on Fri Feb 1 17:19:16 2019 GMT.